Myos Corporation is a biopharmaceutical company focused on discovering, developing and commercializing novel muscle health and performance technologies. The company's research is centered around myostatin, a protein that regulates muscle growth and differentiation. Myos aims to address various muscle-related disorders and improve muscle function for athletes and aging populations.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

8 Patents

#3 in Cedar Knolls, NJ

#1,347 in New Jersey

#35,954 in US

Cedar Knolls, NJ, United States of America

Myos Corporation

Forward Citations = 9

10 inventors:

Neerav D Padliya (6 out of 13 patents)

Maghsoud Dariani (6 out of 7 patents)

Joseph Mannello (4 out of 5 patents)

4. Waldemar Buxmann (1 out of 3 patents)

5. Volker Heinz (1 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Myos Corporation. Retrieved from https://idiyas.com/company/myos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]